Nissan Chemical Corporation has finalized an extension of its long-term supply agreement with MSD Animal Health for Fluralaner, the active pharmaceutical ingredient used in the widely distributed veterinary products BRAVECTO and EXZOLT. Developed by MSD Animal Health, these products are available in over 100 countries and rely on the consistent, high-quality supply of Fluralaner from Nissan Chemical.
Deepening a Strategic Partnership
In a move to further strengthen their collaboration, Nissan Chemical and MSD Animal Health have agreed to initiate a joint research and development program. The strategic R&D alliance aims to create new solutions in animal health, leveraging the strengths of both organizations to drive innovation and expand their global footprint in the veterinary pharmaceutical sector.
Commitment to Growth and Stability
With this extended agreement, Nissan Chemical reaffirms its commitment to delivering a reliable, long-term supply of Fluralaner. As reported by indiapharmapost.com, the company also plans to enhance the competitiveness of its veterinary drug business by broadening its product portfolio and investing in sustainable growth through innovation and collaboration.
